Κατηγορία: Δημοσιεύσεις
-
«Ηπατολογικά προβλήματα σχετιζόμενα με την κατάχρηση οινοπνεύματος»
Δ.Δημητρουλόπουλος, Ε.Πετρουλάκη, Ε.Παρασκευάς, Στο: Κατάχρηση- Εξάρτηση Οινοπνεύματος :κλινικά προβλήματα- θεραπευτική αντιμετώπιση. Εκδόσεις ITACA
-
Peginterferon/ribavirin Treatment Achieve Higher Compliance Rate in Methadone maintenanceChronic HCV infected Patiens Than withInterferon/ribavirin Combination
Dimitris Dimitroulopoulos,Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, KlisthenisTsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas. Gastroenterology April 2005 Volume 128. Number 4. Suppl 2
-
Peginterferon/ ribavirintreatment achieves a higher compliance rate than interferon/ribavirincombination in patients chronically infected with HCV on methadonemaintenance
Dimitrios Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil ParaskevasEuropean Journal of Gastroenterology & Hepatology Deceber 2009,Volume 21
-
Methadone treatment: Hepatitis infection and liver
Mavroides N,Douzenis A, Tsaklakidou D, Petroulaki E, Kokoris C4ο International Meetingof IGSC Organisation, Athens,December 1996
-
High compliance rate in Methadone maintenance HCV patiens with PegylatedInterferon a Plus Ribavirin than with Interferon a plus Ribavirin combination
Dimitroulopoulos D., Petroulaki E., Manolakopoulos S., AnagnostouO., Tsaklakidou D., Xinopoulos D., Tsamakidis K., Tzourmakliotis D., Paraskevas E.20th World Congress of Gastroenterology, Montreal Canada, 2005
-
Peginterferon /ribavirin Treatment Achieve Higher Compliance Rate inMethadone maintenance Chronic HCVinfected Patiens Than with Interferon/ribavirin Combination
Dimitris Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas106th Annual Meeting of the American Gastroenterological Association,Chicago USA,May 2005
-
AntiHCV treatment outcome in drug users is associatedwith buprenorfine use and adherence totreatment
Anagnostou O1,Tsirogianni E1, Goulis I2, Moursellas A1,Kollia S1, Petroulaki E1, Dimitroulopoulos D3, Micha A1, Manolakopoulos S4
-
OKANA- Greek Organisation AgainstDrugs, 2Aristoteleion University Of Thessaloniki Medical School,
3 Hellenic Anticancer Institute,”Saint Savvas” Hospital, 4 Athens University Medical School Latent TB infection among injection usersin methadone programs in Greece P.Katsaounou, E.Petroulaki, K.Kougianos, M.Gaggadi,G. Politis ATS May2006
-
Hepatitis C treatment for intravenous drugusers under substitution in real life
O.Anagnostou, E.Tsirogianni, I.Goulis, S.Kollia, E.Petroulaki, D,Dimitroulopoulos, A.Micha, A.Moursellas, S. Manolakopoulos
-
OKANA- Greek Organisation Against Drugs, 2 Aristoteleion University Of Thessaloniki Medical School, 3 Hellenic Anticancer Institute, “Saint Savvas” Hospital,
4 Athens University Medical School 1st International Symposium onHepatitis Care in Substance Users September 2009